Pharmacological Modulation of Antigen-Induced Airway Hyperresponsiveness by Thromboxane A2 Inhibitors in Guinea Pigs

The effects of OKY-046 (thromboxane A2 (TXA2) synthetase inhibitor) and ONO-3708 (TXA2 receptor antagonist) on antigen-induced airway hyperreactivity in guinea pigs were investigated. Ketotifen was used as a reference drug. Seven inhalations of an antigen into actively sensitized animals resulted in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biological & pharmaceutical bulletin 1993/11/15, Vol.16(11), pp.1099-1103
Hauptverfasser: NAGAI, Hiroichi, TSUJI, Fumio, GOTO, Shouichi, KODA, Akihide
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1103
container_issue 11
container_start_page 1099
container_title Biological & pharmaceutical bulletin
container_volume 16
creator NAGAI, Hiroichi
TSUJI, Fumio
GOTO, Shouichi
KODA, Akihide
description The effects of OKY-046 (thromboxane A2 (TXA2) synthetase inhibitor) and ONO-3708 (TXA2 receptor antagonist) on antigen-induced airway hyperreactivity in guinea pigs were investigated. Ketotifen was used as a reference drug. Seven inhalations of an antigen into actively sensitized animals resulted in an increase in airway reactivity to acetylcholine. Twenty-four hours after the final inhalation, the number of leukocytes (macrophages, neutrophils, eosinophils and lymphocytes) and the quantity of mediators (thromboxane B2, leukotriene D4 and histamine) in bronchoalveolar lavage fluid increased.All examined drugs inhibited the antigen-induced airway hyperreactivity to acetylcholine. Whereas ketotifen inhibited an accumulation of inflammatory cells (eosinophils and neutrophils) in bronchoalveolar lavage fluid, OKY-046 and ONO-3708 had no effect on the accumulation of inflammatory cells. OKY-046, but not ketotifen and ONO-3708, inhibited an increase of thromboxane B2 in the bronchoalveolar lavage fluid after antigen provocation.These results suggest the participation of TXA2 in the onset of antigen-induced airway hyperresponsiveness in guinea pigs, and the efficacy of TXA2 inhibitors, without affecting the accumulation of inflammatory cells in bronchoalveolar lavage fluid.
doi_str_mv 10.1248/bpb.16.1099
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76223287</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>76223287</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5239-ebad8c56bb609c6f338d44509b32fac33dc2e9effd1cf2d921eb9cd700e41d3e3</originalsourceid><addsrcrecordid>eNpdkUuP0zAURi0EGsrAijWSJRAblOJH4sTLasTMVBrELIa15cdN6yqxi50A_fe4tHTBxl58R_dc3Q-ht5QsKau7z2ZvllQsKZHyGVpQXrdVw2jzHC2IpF0laNO9RK9y3hFCWsL4FbrqOGWd4As0PW51GrWNQ9x4qwf8Nbp50JOPAccer8LkNxCqdXCzBYdXPv3SB3x_2ENKkPcxZP8TAuSMzQE_bVMcTfytA-AVw-uw9cZPMWXsA76bfQCNH_0mv0Yvej1keHP-r9H32y9PN_fVw7e79c3qobIN47ICo11nG2GMINKKnvPO1XVDpOGs15ZzZxlI6HtHbc-cZBSMtK4lBGrqOPBr9PE0d5_ijxnypEafLQxDWTDOWbWCMc66toDv_wN3cU6h7KZoXUvaCElooT6dKJtizgl6tU9-1OmgKFHHJlRpQlGhjk0U-t155mxGcBf2fPqSfzjnOpfD90kH6_MF47LruDhKb0_YLk96A5dcp8nbAY5KWmx_tfTfW_wXwJaCFQT-ByA-qrU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1449156901</pqid></control><display><type>article</type><title>Pharmacological Modulation of Antigen-Induced Airway Hyperresponsiveness by Thromboxane A2 Inhibitors in Guinea Pigs</title><source>J-STAGE Free</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Free Full-Text Journals in Chemistry</source><creator>NAGAI, Hiroichi ; TSUJI, Fumio ; GOTO, Shouichi ; KODA, Akihide</creator><creatorcontrib>NAGAI, Hiroichi ; TSUJI, Fumio ; GOTO, Shouichi ; KODA, Akihide</creatorcontrib><description>The effects of OKY-046 (thromboxane A2 (TXA2) synthetase inhibitor) and ONO-3708 (TXA2 receptor antagonist) on antigen-induced airway hyperreactivity in guinea pigs were investigated. Ketotifen was used as a reference drug. Seven inhalations of an antigen into actively sensitized animals resulted in an increase in airway reactivity to acetylcholine. Twenty-four hours after the final inhalation, the number of leukocytes (macrophages, neutrophils, eosinophils and lymphocytes) and the quantity of mediators (thromboxane B2, leukotriene D4 and histamine) in bronchoalveolar lavage fluid increased.All examined drugs inhibited the antigen-induced airway hyperreactivity to acetylcholine. Whereas ketotifen inhibited an accumulation of inflammatory cells (eosinophils and neutrophils) in bronchoalveolar lavage fluid, OKY-046 and ONO-3708 had no effect on the accumulation of inflammatory cells. OKY-046, but not ketotifen and ONO-3708, inhibited an increase of thromboxane B2 in the bronchoalveolar lavage fluid after antigen provocation.These results suggest the participation of TXA2 in the onset of antigen-induced airway hyperresponsiveness in guinea pigs, and the efficacy of TXA2 inhibitors, without affecting the accumulation of inflammatory cells in bronchoalveolar lavage fluid.</description><identifier>ISSN: 0918-6158</identifier><identifier>EISSN: 1347-5215</identifier><identifier>DOI: 10.1248/bpb.16.1099</identifier><identifier>PMID: 8312863</identifier><language>eng</language><publisher>Tokyo: The Pharmaceutical Society of Japan</publisher><subject>Acetylcholine ; Administration, Inhalation ; airway hyperreactivity ; airway inflammation ; Animals ; Biological and medical sciences ; Bronchi - drug effects ; Bronchi - pathology ; Bronchial Hyperreactivity - drug therapy ; Bronchial Hyperreactivity - pathology ; Bronchial Hyperreactivity - physiopathology ; Bronchoalveolar Lavage Fluid - chemistry ; Bronchoalveolar Lavage Fluid - cytology ; Guinea Pigs ; Histamine and antagonists. Allergy ; Ketotifen - pharmacology ; Leukocyte Count - drug effects ; Male ; Medical sciences ; Methacrylates - administration &amp; dosage ; Methacrylates - pharmacology ; OKY-046 ; ONO-3708 ; Pharmacology. Drug treatments ; thromboxane A2 ; Thromboxane A2 - administration &amp; dosage ; Thromboxane A2 - analogs &amp; derivatives ; Thromboxane A2 - antagonists &amp; inhibitors ; Thromboxane A2 - pharmacology ; Thromboxane A2 - physiology ; Thromboxane-A Synthase - antagonists &amp; inhibitors ; Trachea - drug effects ; Trachea - pathology</subject><ispartof>Biological and Pharmaceutical Bulletin, 1993/11/15, Vol.16(11), pp.1099-1103</ispartof><rights>The Pharmaceutical Society of Japan</rights><rights>1994 INIST-CNRS</rights><rights>Copyright Japan Science and Technology Agency 1993</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5239-ebad8c56bb609c6f338d44509b32fac33dc2e9effd1cf2d921eb9cd700e41d3e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1877,4010,27900,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3988361$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8312863$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>NAGAI, Hiroichi</creatorcontrib><creatorcontrib>TSUJI, Fumio</creatorcontrib><creatorcontrib>GOTO, Shouichi</creatorcontrib><creatorcontrib>KODA, Akihide</creatorcontrib><title>Pharmacological Modulation of Antigen-Induced Airway Hyperresponsiveness by Thromboxane A2 Inhibitors in Guinea Pigs</title><title>Biological &amp; pharmaceutical bulletin</title><addtitle>Biol Pharm Bull</addtitle><description>The effects of OKY-046 (thromboxane A2 (TXA2) synthetase inhibitor) and ONO-3708 (TXA2 receptor antagonist) on antigen-induced airway hyperreactivity in guinea pigs were investigated. Ketotifen was used as a reference drug. Seven inhalations of an antigen into actively sensitized animals resulted in an increase in airway reactivity to acetylcholine. Twenty-four hours after the final inhalation, the number of leukocytes (macrophages, neutrophils, eosinophils and lymphocytes) and the quantity of mediators (thromboxane B2, leukotriene D4 and histamine) in bronchoalveolar lavage fluid increased.All examined drugs inhibited the antigen-induced airway hyperreactivity to acetylcholine. Whereas ketotifen inhibited an accumulation of inflammatory cells (eosinophils and neutrophils) in bronchoalveolar lavage fluid, OKY-046 and ONO-3708 had no effect on the accumulation of inflammatory cells. OKY-046, but not ketotifen and ONO-3708, inhibited an increase of thromboxane B2 in the bronchoalveolar lavage fluid after antigen provocation.These results suggest the participation of TXA2 in the onset of antigen-induced airway hyperresponsiveness in guinea pigs, and the efficacy of TXA2 inhibitors, without affecting the accumulation of inflammatory cells in bronchoalveolar lavage fluid.</description><subject>Acetylcholine</subject><subject>Administration, Inhalation</subject><subject>airway hyperreactivity</subject><subject>airway inflammation</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Bronchi - drug effects</subject><subject>Bronchi - pathology</subject><subject>Bronchial Hyperreactivity - drug therapy</subject><subject>Bronchial Hyperreactivity - pathology</subject><subject>Bronchial Hyperreactivity - physiopathology</subject><subject>Bronchoalveolar Lavage Fluid - chemistry</subject><subject>Bronchoalveolar Lavage Fluid - cytology</subject><subject>Guinea Pigs</subject><subject>Histamine and antagonists. Allergy</subject><subject>Ketotifen - pharmacology</subject><subject>Leukocyte Count - drug effects</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Methacrylates - administration &amp; dosage</subject><subject>Methacrylates - pharmacology</subject><subject>OKY-046</subject><subject>ONO-3708</subject><subject>Pharmacology. Drug treatments</subject><subject>thromboxane A2</subject><subject>Thromboxane A2 - administration &amp; dosage</subject><subject>Thromboxane A2 - analogs &amp; derivatives</subject><subject>Thromboxane A2 - antagonists &amp; inhibitors</subject><subject>Thromboxane A2 - pharmacology</subject><subject>Thromboxane A2 - physiology</subject><subject>Thromboxane-A Synthase - antagonists &amp; inhibitors</subject><subject>Trachea - drug effects</subject><subject>Trachea - pathology</subject><issn>0918-6158</issn><issn>1347-5215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkUuP0zAURi0EGsrAijWSJRAblOJH4sTLasTMVBrELIa15cdN6yqxi50A_fe4tHTBxl58R_dc3Q-ht5QsKau7z2ZvllQsKZHyGVpQXrdVw2jzHC2IpF0laNO9RK9y3hFCWsL4FbrqOGWd4As0PW51GrWNQ9x4qwf8Nbp50JOPAccer8LkNxCqdXCzBYdXPv3SB3x_2ENKkPcxZP8TAuSMzQE_bVMcTfytA-AVw-uw9cZPMWXsA76bfQCNH_0mv0Yvej1keHP-r9H32y9PN_fVw7e79c3qobIN47ICo11nG2GMINKKnvPO1XVDpOGs15ZzZxlI6HtHbc-cZBSMtK4lBGrqOPBr9PE0d5_ijxnypEafLQxDWTDOWbWCMc66toDv_wN3cU6h7KZoXUvaCElooT6dKJtizgl6tU9-1OmgKFHHJlRpQlGhjk0U-t155mxGcBf2fPqSfzjnOpfD90kH6_MF47LruDhKb0_YLk96A5dcp8nbAY5KWmx_tfTfW_wXwJaCFQT-ByA-qrU</recordid><startdate>1993</startdate><enddate>1993</enddate><creator>NAGAI, Hiroichi</creator><creator>TSUJI, Fumio</creator><creator>GOTO, Shouichi</creator><creator>KODA, Akihide</creator><general>The Pharmaceutical Society of Japan</general><general>Maruzen</general><general>Japan Science and Technology Agency</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>1993</creationdate><title>Pharmacological Modulation of Antigen-Induced Airway Hyperresponsiveness by Thromboxane A2 Inhibitors in Guinea Pigs</title><author>NAGAI, Hiroichi ; TSUJI, Fumio ; GOTO, Shouichi ; KODA, Akihide</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5239-ebad8c56bb609c6f338d44509b32fac33dc2e9effd1cf2d921eb9cd700e41d3e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Acetylcholine</topic><topic>Administration, Inhalation</topic><topic>airway hyperreactivity</topic><topic>airway inflammation</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Bronchi - drug effects</topic><topic>Bronchi - pathology</topic><topic>Bronchial Hyperreactivity - drug therapy</topic><topic>Bronchial Hyperreactivity - pathology</topic><topic>Bronchial Hyperreactivity - physiopathology</topic><topic>Bronchoalveolar Lavage Fluid - chemistry</topic><topic>Bronchoalveolar Lavage Fluid - cytology</topic><topic>Guinea Pigs</topic><topic>Histamine and antagonists. Allergy</topic><topic>Ketotifen - pharmacology</topic><topic>Leukocyte Count - drug effects</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Methacrylates - administration &amp; dosage</topic><topic>Methacrylates - pharmacology</topic><topic>OKY-046</topic><topic>ONO-3708</topic><topic>Pharmacology. Drug treatments</topic><topic>thromboxane A2</topic><topic>Thromboxane A2 - administration &amp; dosage</topic><topic>Thromboxane A2 - analogs &amp; derivatives</topic><topic>Thromboxane A2 - antagonists &amp; inhibitors</topic><topic>Thromboxane A2 - pharmacology</topic><topic>Thromboxane A2 - physiology</topic><topic>Thromboxane-A Synthase - antagonists &amp; inhibitors</topic><topic>Trachea - drug effects</topic><topic>Trachea - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>NAGAI, Hiroichi</creatorcontrib><creatorcontrib>TSUJI, Fumio</creatorcontrib><creatorcontrib>GOTO, Shouichi</creatorcontrib><creatorcontrib>KODA, Akihide</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Biological &amp; pharmaceutical bulletin</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>NAGAI, Hiroichi</au><au>TSUJI, Fumio</au><au>GOTO, Shouichi</au><au>KODA, Akihide</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacological Modulation of Antigen-Induced Airway Hyperresponsiveness by Thromboxane A2 Inhibitors in Guinea Pigs</atitle><jtitle>Biological &amp; pharmaceutical bulletin</jtitle><addtitle>Biol Pharm Bull</addtitle><date>1993</date><risdate>1993</risdate><volume>16</volume><issue>11</issue><spage>1099</spage><epage>1103</epage><pages>1099-1103</pages><issn>0918-6158</issn><eissn>1347-5215</eissn><abstract>The effects of OKY-046 (thromboxane A2 (TXA2) synthetase inhibitor) and ONO-3708 (TXA2 receptor antagonist) on antigen-induced airway hyperreactivity in guinea pigs were investigated. Ketotifen was used as a reference drug. Seven inhalations of an antigen into actively sensitized animals resulted in an increase in airway reactivity to acetylcholine. Twenty-four hours after the final inhalation, the number of leukocytes (macrophages, neutrophils, eosinophils and lymphocytes) and the quantity of mediators (thromboxane B2, leukotriene D4 and histamine) in bronchoalveolar lavage fluid increased.All examined drugs inhibited the antigen-induced airway hyperreactivity to acetylcholine. Whereas ketotifen inhibited an accumulation of inflammatory cells (eosinophils and neutrophils) in bronchoalveolar lavage fluid, OKY-046 and ONO-3708 had no effect on the accumulation of inflammatory cells. OKY-046, but not ketotifen and ONO-3708, inhibited an increase of thromboxane B2 in the bronchoalveolar lavage fluid after antigen provocation.These results suggest the participation of TXA2 in the onset of antigen-induced airway hyperresponsiveness in guinea pigs, and the efficacy of TXA2 inhibitors, without affecting the accumulation of inflammatory cells in bronchoalveolar lavage fluid.</abstract><cop>Tokyo</cop><pub>The Pharmaceutical Society of Japan</pub><pmid>8312863</pmid><doi>10.1248/bpb.16.1099</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0918-6158
ispartof Biological and Pharmaceutical Bulletin, 1993/11/15, Vol.16(11), pp.1099-1103
issn 0918-6158
1347-5215
language eng
recordid cdi_proquest_miscellaneous_76223287
source J-STAGE Free; MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Free Full-Text Journals in Chemistry
subjects Acetylcholine
Administration, Inhalation
airway hyperreactivity
airway inflammation
Animals
Biological and medical sciences
Bronchi - drug effects
Bronchi - pathology
Bronchial Hyperreactivity - drug therapy
Bronchial Hyperreactivity - pathology
Bronchial Hyperreactivity - physiopathology
Bronchoalveolar Lavage Fluid - chemistry
Bronchoalveolar Lavage Fluid - cytology
Guinea Pigs
Histamine and antagonists. Allergy
Ketotifen - pharmacology
Leukocyte Count - drug effects
Male
Medical sciences
Methacrylates - administration & dosage
Methacrylates - pharmacology
OKY-046
ONO-3708
Pharmacology. Drug treatments
thromboxane A2
Thromboxane A2 - administration & dosage
Thromboxane A2 - analogs & derivatives
Thromboxane A2 - antagonists & inhibitors
Thromboxane A2 - pharmacology
Thromboxane A2 - physiology
Thromboxane-A Synthase - antagonists & inhibitors
Trachea - drug effects
Trachea - pathology
title Pharmacological Modulation of Antigen-Induced Airway Hyperresponsiveness by Thromboxane A2 Inhibitors in Guinea Pigs
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T20%3A34%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacological%20Modulation%20of%20Antigen-Induced%20Airway%20Hyperresponsiveness%20by%20Thromboxane%20A2%20Inhibitors%20in%20Guinea%20Pigs&rft.jtitle=Biological%20&%20pharmaceutical%20bulletin&rft.au=NAGAI,%20Hiroichi&rft.date=1993&rft.volume=16&rft.issue=11&rft.spage=1099&rft.epage=1103&rft.pages=1099-1103&rft.issn=0918-6158&rft.eissn=1347-5215&rft_id=info:doi/10.1248/bpb.16.1099&rft_dat=%3Cproquest_cross%3E76223287%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1449156901&rft_id=info:pmid/8312863&rfr_iscdi=true